Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis (Q36600260)

15 August 2017

1 reference

title

Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis (English)

1 reference

15 August 2017

1 reference

Demosthenes Bouros

1

1 reference

15 August 2017

Katerina M Antoniou

series ordinal

2

1 reference

15 August 2017

Argyris Tzouvelekis

series ordinal

3

1 reference

15 August 2017

Nikolaos M Siafakas

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Expert Opinion on Biological Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1051-1060

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

15 August 2017

1 reference

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Current and future therapeutic approaches in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Clinical advances in the diagnosis and therapy of the interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Interferons and their application in the diseases of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Antioxidant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Long-term treatment of osteopetrosis with recombinant human interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

NIH conference. Immunomodulators in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Effects of nasal pressure support on ventilation and inspiratory work in normocapnic and hypercapnic patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Evidence of IL-18 as a novel angiogenic mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

The clinical course of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

Interferon-γ1b Therapy in Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.10.1051

10.1517/14712598.6.10.1051

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference